News & Publications

With philanthropic support, the Nghiem Lab carried out research that has shown that for MCC, narrower surgical margins, when given with radiation, provide excellent protection against local disease recurrence.

A recent study by the Nghiem Lab, supported by philanthropy, found that a baseline PET-CT scan discovered ‘hidden’ disease in 1 in 6 patients with MCC, dramatically changing their treatment plans.

We will hold the 2021 Multicenter Merkel Interest Group (MMIG) meeting on Friday, June 4th, 11 am-1 pm EDT / 8 am-10 am PDT via Zoom. Please email mccteam@uw.edu for an invitation with the zoom details. If you have an interesting topic to present, please let us know as we have a few avai...

When you get your chance to receive the COVID vaccine, unless there is a specific contraindication, you should do it!  Many patients have been asking this very reasonable question. Our team has in every case said to get vaccinated, whether or not the patient is on therapy to alter their immune resp...

Dear friends of Merkel cell carcinoma research, As we conclude this unprecedented year, I would like to convey Team Merkel’s appreciation of your support. Although it was a challenging year, 2020 was also one of many exciting milestones in Merkel cell research that I am excited to share with yo...

Take-Home Message Using the National Cancer Database, cases of stage I–III Merkel cell carcinoma (MCC; N=11,119) were sorted into those treated at high treatment center volume (TCV) institutions versus low TVC institutions. At a median follow-up of 28.8 months, the 2-year overall survival was...

The STAMP trial is currently recruiting participants at sites all across the country. This phase III trial studies how well pembrolizumab works compared to standard of care observation in treating patients with stage I-III Merkel cell cancer that has been completely removed by surgery (resect...

We are very excited to announce that this year we held our first ever online Merkel CELLebration in lieu of our annual Merkel Dinner. The event took place on Zoom on Monday, September 14, 2020 from 3-5 PM PDT. The event included a presentation of new research and clinical developments in MCC, as ...

Nghiem Lab research team demonstrates effectiveness of Single fraction adjuvant radiation therapy for treating patients with Merkel cell carcinoma (MCC). The team, consisting of investigators from UW Divisions of Dermatology and Medical Oncology and the Departments of Radiation Oncology Radiology, ...